Tyrosine kinase inhibitors for acute respiratory failure due to non-small-cell lung cancer involvement in intensive care unit
Chest. 2021 Jul 21:S0012-3692(21)01358-1. doi: 10.1016/j.chest.2021.06.079. Online ahead of print.NO ABSTRACTPMID:34302842 | DOI:10.1016/j.chest.2021.06.079
Source: Chest - Category: Respiratory Medicine Authors: Y Tandjaoui-Lambiotte Y Akrour A Gibelin F Gonzalez A Stoclin A S Moreau P Jaubert A Oppenheimer B Duchemann S Gaudry GRRROH study group: F El Kouari E De Montmollin M Pineton de Chambrun F Wallet A Lautrette N Dufour D Contou J D Ricard R Persichini J Ma Source Type: research
More News: Cancer | Cancer & Oncology | Intensive Care | Lung Cancer | Non-Small Cell Lung Cancer | Respiratory Medicine | Study